, or OH ؊ but are indistinguishable from wild-type cells under standard culture conditions. To characterize regulatory pathways that may overlap with calcineurin, we performed a synthetic lethal screen to identify mutants that require calcineurin on standard growth media. The characterization of one such mutant, cnd1-8, is presented. The CND1 gene was cloned, and sequence analysis predicts that it encodes a novel protein 1,876 amino acids in length with multiple membrane-spanning domains. CND1 is identical to the gene identified previously as FKS1, ETG1, and CWH53. cnd1 mutants are sensitive to FK506 and cyclosporin A and exhibit slow growth that is improved by the addition of osmotic stabilizing agents. This osmotic agent-remedial growth defect and microscopic evidence of spontaneous cell lysis in cnd1 cultures suggest that cell integrity is compromised in these mutants. Mutations in the genes for yeast protein kinase C (pkc1) and a MAP kinase (mpk1/slt2) disrupt a Ca
2؉
-dependent signaling pathway required to maintain a normal cell wall and cell integrity. We show that pkc1 and mpk1/slt2 growth defects are more severe in the absence of calcineurin function and less severe in the presence of a constitutively active form of calcineurin. These observations suggest that calcineurin and protein kinase C perform independent but physiologically related functions in yeast cells. We show that several mutants that lack a functional vacuolar H ؉ -ATPase (vma) require calcineurin for vegetative growth. We discuss possible roles for calcineurin in regulating intracellular ion homeostasis and in maintaining cell integrity.
The role of Ca 2ϩ as a second messenger has been well established (9) . A change in the intracellular concentration of this ion acts as a signal that can effect a variety of physiological changes in different cell types. One of the mechanisms by which Ca 2ϩ acts is by binding to and activating calmodulin, enabling this intracellular calcium receptor to activate a number of target enzymes. Among these target enzymes are kinases and phosphatases that alter cell physiology by modulating the phosphorylation state of many proteins.
Several components of Ca 2ϩ -mediated signaling pathways in higher eukaryotes have been identified in Saccharomyces cerevisiae, in which they also function in a regulatory capacity. Protein kinase C, for example, encoded by the PKC1 gene, regulates a mitogen-activated protein (MAP) kinase-containing signal transduction pathway that is required to maintain the integrity of the yeast cell (reviewed in reference 19) . Yeast mutants lacking phospholipase C, encoded by the PLC1 gene, display pleiotropic phenotypes, including osmotic sensitivity, inability to grow on some carbon sources, and increased chromosome loss (19a, 51, 63) . Yeast cells also possess calmodulin, and this protein is essential for growth (15) . However, the Ca 2ϩ -dependent signaling properties of calmodulin appear to be dispensable for vegetative growth, as mutants that contain a calmodulin defective for all Ca 2ϩ binding are viable (23) . We have focused on trying to understand the role of calmodulinmediated Ca 2ϩ signaling in yeast cells by establishing the functions of one particular calmodulin-regulated enzyme, the Ca 2ϩ /calmodulin-dependent protein phosphatase calcineurin (or PP2B).
In many cell types, including mammalian T cells and plant guard cells, this enzyme plays a critical role in mediating Ca 2ϩ -dependent signaling (41, 43) . Although some proteins have been proposed as candidate substrates for calcineurin in vivo, in no case has a calcineurin-containing signal transduction pathway been defined. In part, the functions of calcineurin in different cell types has been assessed by examining the effects of the drugs FK506 and cyclosporin A. In the presence of FK506 and cyclosporin A, FK506-binding proteins and cyclophilins (the intracellular receptors for these drugs) bind to and inactivate calcineurin; thus, these compounds are specific inhibitors of calcineurin both in vivo and in vitro (reviewed in reference 41) .
In yeast cells, it is possible to use genetic approaches to examine calcineurin function. Calcineurin has been purified from yeast extracts (14) , and the genes encoding its components have been identified. Calcineurin is a heterodimer; two genes, CNA1/CMP1 and CNA2/CMP2, encode functionally redundant catalytic subunits of the enzyme, and the CNB1 gene encodes a necessary regulatory subunit (13, 14, 33, 42) . Cells lacking functional calcineurin (i.e., cna1 cna2 mutants and cnb1 mutants) are viable, indicating that this phosphatase is not required for vegetative growth under most conditions. However, calcineurin-deficient cells do display specific growth defects. Calcineurin mutants fail to grow when high concentrations of any of a number of different ions (Na (6, 12, 45, 46) . Also, calcineurin mutants die during continuous exposure to pheromone, as do wild-type cells that are deprived of Ca 2ϩ (12, 29) . These phenotypes suggest that calcineurin participates in regulating the intracellular concentration of several ions. Calcineurin mutants may display no dramatic phenotypes under optimal growth conditions because other regulatory pathways in the cell exist that perform similar functions. To address this possibility, we have identified mutants that depend on calcineurin for vegetative growth under standard laboratory growth conditions. The characterization of some of those mutants is presented here. First, we describe the isolation of CND1, a novel gene encoding a putative integral membrane protein that is essential in calcineurin mutants. cnd1 mutants are sensitive to FK506 and cyclosporin A, have an increased tendency to lyse, and exhibit poor growth that is improved by the addition of osmotic stabilizing agents. These observations suggest that the CND1 gene product is required to maintain cell integrity. Spontaneous lysis and osmotic agent-remedial growth defects are characteristic of mutations that disrupt the PKC1-regulated MAP kinase signal transduction pathway. Mutants with mutations in this pathway, such as pkc1, bck1/slk1, and mpk1/slt2, display alterations in cell wall structure and composition and defects in polarized growth (10, 30, 35-37, 44, 49, 58, 61) . We show that, like cnd1 mutants, pkc1 and mpk1/ slt2 mutants depend on calcineurin for vegetative growth. Furthermore, a constitutively active form of calcineurin partially suppresses the spontaneous lysis of pkc1 and mpk1/slt2 mutants. These findings suggest that calcineurin defines a second Ca 2ϩ -dependent pathway which acts together with the PKC1 pathway to maintain the integrity of the cell. Finally, we report that mutations in several VMA genes, known to encode necessary subunits of the vacuolar H ϩ -ATPase (reviewed in reference 2), are lethal in combination with calcineurin mutations. We discuss the possible implications of these genetic interactions for understanding the physiological functions of calcineurin.
MATERIALS AND METHODS
Yeast strains, media, and general methods. All yeast strains used in this study are listed in Table 1 . Standard procedures were used for genetic manipulation of yeast strains (57) , and the media and culture conditions were those recommended (57) except that nutritional supplements in synthetic media were added at twice the specified level. All galactose-containing media also contained 0.2% sucrose. For sectoring assays, synthetic medium containing a reduced concentration of adenine was used (6 mg/liter [26] ). Medium containing 5-fluoroorotic acid (5FOA) was made as described before (5) . When noted, salts or sorbitol was added to YP medium at the specified level. FK506 was obtained from Fugisawa, Inc. A stock solution of FK506 (5 mg/ml in 90% ethanol-10% Tween 20) was added to liquid or solid media to the final concentration specified. Cyclosporin A was obtained from Sandoz. A stock solution of cyclosporin A (30 mg/ml in 90% ethanol-10% Tween 20) was added to liquid or solid media to the final concentration specified. DNA was introduced into yeast cells by lithium acetate transformation (3) and into bacteria by electroporation (3) . Yeast genomic and plasmid DNAs were isolated as described before (3) . The location of CND1 on the physical map of the yeast genome was determined by hybridization of a radiolabeled 2.2-kb HindIII-ClaI fragment to a set of phages carrying ordered segments of S. cerevisiae chromosomal DNA (ATCC 77284 [40] ). Hybridization analyses of DNA transferred to Hybond Nϩ membranes (Amersham) were performed by standard procedures (3). Radioactive probes were synthesized by using random primers (Pharmacia) and [␣- Plasmids. Plasmid pCNA2-29 (used in the sectoring screen; see below) was constructed by inserting a 2.1-kb BamHI-XhoI fragment containing the CNA2 open reading frame (ORF) from pCNA2-R (27) into pMW29 (62) . The construction of pCNA2-R will be described in a future manuscript. It contains the entire CNA2 ORF, modified by site-directed mutagenesis to introduce a BamHI site just upstream of the CNA2 initiator ATG, inserted into pBluescript (Stratagene). Low-copy-number plasmids expressing CNA1 (pCNA1-314) and CNA2 (pCNA2-314) were constructed by using pRS314 (59) . A high-copy-number plasmid expressing CNA2 was constructed by using YEp352 (25) . A similar plasmid containing CNA2⌬, a truncated version of CNA2, was created by changing amino acid 505 (a leucine) to a stop codon by site-directed mutagenesis (3) . CNA2⌬ lacks the calmodulin-binding domain and the putative C-terminal inhibitory domain of CNA2 (13) . pCND1-315, a low-copy (cen) plasmid containing the CND1 ORF and the LEU2 gene, was constructed by inserting a 9-kb genomic SpeI-PstI fragment into pRS315. pCND1-YEp, a high-copy plasmid containing the CND1 ORF and the LEU2 gene, was constructed by inserting the same fragment into YEp351 (25) . A plasmid containing a dominant activated form of BCK1, pRS314[BCK1-20], has been described (36) .
Isolation of mutants that require calcineurin for growth. Strain PGY2, used to screen for calcineurin-dependent mutants, was constructed as follows. First, the (57) . The mutagenized culture was plated (approx. 200 colonies per plate), and 74,000 colonies were screened visually to identify those that failed to sector. Colonies without sectors were retested for nonsectoring colony morphology and the inability to grow on dextrose-containing media and on galactose media containing 5FOA. A total of six strains that both failed to sector and failed to grow on dextrose-containing media and 5FOA-galactose media were identified. Genetic analysis of calcineurin-dependent mutants. All six mutants were mated to YPH500 and/or MCY 3-1D, and the resulting diploids were tested for growth on SCGal solid medium containing FK506 (5 g/ml). Growth on this medium indicated that the mutation was recessive. These diploids were sporulated, and the haploid segregants of individual tetrads were tested for FK506 sensitivity. A 2:2 segregation of FK506 sensitivity indicated that it resulted from a single mutation. The cnd1-8 mutant was backcrossed to a nonmutagenized strain for two generations to generate the FK506-sensitive strain PGY4. Complementation tests were performed as follows. Calcineurin-dependent strains were mated to each other (strains of the ␣ mating type were generated from the crosses described above), and the diploids were tested for FK506 sensitivity, with lack of sensitivity indicating complementation.
Isolation and characterization of clones complementing calcineurin synthetic lethal mutation. A genomic library in p366, a low-copy cen plasmid containing LEU2 (ATCC 77162 [60] ), was transformed into strain PGY2-8 (which cannot grow on dextrose), transformants were selected on plates containing dextrose and lacking leucine and purified, and Ura Ϫ derivatives were isolated on 5FOA medium (to cure pCNA2-29). To eliminate transformants that contained plasmids encoding CNA1 or CNA2, all transformants were screened for FK506 sensitivity. Only FK506-insensitive transformants were selected for further analysis. Plasmid DNA was isolated from these transformants and analyzed by restriction analysis. Plasmids containing an insert were retransformed into PGY2-8 to test for their ability to support growth of this strain on medium containing dextrose and lacking leucine. Three plasmids containing the identical insert were identified by this analysis. Determination of the minimal complementing region was assessed by the ability of low-copy (cen) plasmids containing DNA fragments from the CND1 region to support growth of PGY2-8 on dextrose medium.
Construction of cnd1 alleles. The cnd1⌬1::URA3 hisG allele was assembled in pBluescript from a 1.2-kb PstI-EcoRI fragment (from CND1), a 3.8-kb EcoRIBamHI fragment containing URA3 flanked by the Salmonella hisG sequence (derived from pNKY51 [1] cloned into pBluescript), and a 500-bp BglII-SpeI fragment (from CND1). The cnd1⌬1::URA3 hisG allele was then excised as a 5.5-kb SphI-SpeI linear fragment and introduced into yeast cells by transformation. The genotype of cnd1⌬1::URA3 hisG strains was confirmed by Southern blotting. TRP1 was inserted upstream but tightly linked to a functional CND1 gene as follows. The 2.7-kb PstI-EcoRV fragment that includes the CND1 ATG and upstream region was subcloned into pBluescript and digested with StuI and EcoRI to insert an 830-bp StuI-EcoRI fragment encoding TRP1 (from pJJ281 [31] ). This region was characterized by DNA sequence analysis and does not contain an ORF. A 2.5-kb fragment containing upstream CND1 flanking sequence and TRP1 was excised from this plasmid by digesting with BamHI and ClaI and transformed into YPH500 to create strain PGY6. The TRP1 insertion was confirmed by Southern blotting.
DNA sequencing. Restriction fragments derived from library plasmids were subcloned into Bluescript vectors (Stratagene), and nested deletions were created (24) . Double-stranded DNA templates were prepared according to the manufacturer's instructions (Promega Wizard prep). The nucleotide sequences of both strands were determined by using the deletions and, where necessary, custom-synthesized oligonucleotide primers. The Sequenase version of phage T7 DNA polymerase and nonradioactive nucleotides were obtained from U.S. Biochemicals, and sequencing reactions were conducted according to the manufacturer's instructions. [␣- 35 S]dATP was purchased from Amersham. FK506 and cyclosporin A sensitivity. Sensitivity to FK506 and cyclosporin A was assessed in two ways.
(i) Liquid culture assay. Each strain tested was grown to mid-log phase in either YPDex or YPGal and diluted in duplicate to a final optical density (OD) of 0.05 with the appropriate final concentration of either FK506 or cyclosporin A. All cultures were then incubated at 30ЊC in a shaking water bath until the culture without drug reached an OD at 600 nm (OD 600 ) of 0.9 to 1.1. At this time, all cultures were harvested, and their OD 600 was measured. The relative sensitivities of each strain to each drug were quantitated by comparing the 50% inhibitory concentrations (IC 50 s) (as determined from the data graphed in Fig. 5 ).
(ii) Solid-phase culture assay (halo assay). Plates (either synthetic or YP medium) were inoculated with 2 ϫ 10 6 cells in top agar (0.75% final concentration). A sterile disk saturated with 5 g of FK506 or 50 g of cyclosporin A was immediately placed on the plate, and they were incubated at the appropriate temperature (25 or 30ЊC) for 2 to 4 days.
Microscopic analysis of cultures. Yeast cultures were observed by phasecontrast microscopy at a final magnification of 400ϫ. Methylene blue staining to determine the number of viable cells was performed by adding equal volumes of culture and 0.02% methylene blue-4% sodium citrate solution (29) . The numbers of methylene blue-negative and -positive cells were determined immediately by bright-field microscopy. More than 300 cells of each strain were counted.
Nucleotide sequence accession number. The CND1 sequence was submitted to GenBank and appears there under accession number L35923.
RESULTS
Identification and characterization of mutants that require calcineurin for vegetative growth. Under standard laboratory conditions, the growth and morphology of calcineurin mutants is indistinguishable from that of wild-type cells. Only under specific environmental conditions, for example, in the presence of pheromone, high pH, or high concentrations of Na ϩ or some other cations, do calcineurin mutants display growth and viability defects relative to wild-type cells (6, 12, 45, 47) .
To characterize other regulatory pathways in the cell that may compensate for the lack of calcineurin activity, we have identified mutants that depend on functional calcineurin for vegetative growth on standard growth media. We performed a screen for such synthetic lethal mutations that makes use of a simple colony color or sectoring assay. A haploid yeast strain (PGY1) that contains deletions of both calcineurin regulatory subunits, cna1⌬1::hisG and cna2⌬1::HIS3, ade2, and ade3 was constructed. This strain is adenine requiring, grows on medium containing both dextrose and galactose, and produces white colonies. A centromeric plasmid containing CNA2 driven by the regulated GAL1, 10 promoter, URA3, and ADE3 was transformed into this strain to create PGY2. On galactose-containing medium, cells containing this plasmid express functional calcineurin and produce colonies that are red because of the presence of the ade2 mutation. However, under nonselective conditions, this plasmid is lost at a relatively high frequency, giving rise to red colonies with many white sectors. The white sectors are produced by cells that have lost the plasmid and therefore lack calcineurin.
To isolate mutants that require calcineurin for growth, PGY2 was mutagenized, and potential calcineurin-dependent mutants were identified as solid red colonies that failed to give rise to white sectors. These mutants were further examined to identify those that failed to grow on dextrose-containing medium (when the expression of calcineurin from the plasmid is repressed) and on galactose-containing 5FOA medium (which selects for loss of the URA3-bearing calcineurin expression plasmid). By this screening procedure, we identified five strains whose growth was calcineurin dependent (isolates 6, 8, 112, 116, and 126). We also identified one strain whose growth was significantly decreased in the absence of calcineurin (isolate 106). Each calcineurin-dependent strain was shown, by genetic analysis, to contain a single recessive mutation (see Materials and Methods). Each strain, when transformed with a second centromeric plasmid containing either CNA1 or CNA2, expressed from their endogenous promoters, became able to sector and grow on dextrose-containing medium (data not shown). Thus, each strain contained a single recessive mutation that rendered its growth dependent on either of two possible calcineurin isoforms, Cna1p-containing calcineurin or Cna2p-containing calcineurin. Furthermore, although the strains were originally identified under conditions of calcineurin overexpression (from the GAL1,10 promoter), low levels of calcineurin are sufficient to support their growth.
Calcineurin-dependent mutants are hypersensitive to FK506 and cyclosporin A. The immunosuppressant drugs FK506 and cyclosporin A have been shown to specifically inhibit calcineurin in many different cell types, including yeast cells (reviewed in references 34 and 41). Wild-type yeast cells exposed to relatively low concentrations of FK506 and cyclosporin A grow normally on standard growth media but acquire all the phenotypes of calcineurin mutants (6, 12, 20, 46) . However, strains such as those described above that require calcineurin for vegetative growth should fail to grow when exposed to the same concentrations of these drugs (6, 18, 50) . We found that the five calcineurin-dependent mutants identified in our screen (isolates 6, 8, 112, 116, and 126) did exhibit various degrees of hypersensitivity to FK506 (see Fig. 1 ) and cyclosporin A (data not shown). Isolate 8 was the most sensitive to both drugs. Isolate 106, which had a decreased growth rate in the absence of calcineurin, also showed slow growth in the presence of FK506 and cyclosporin A (data not shown).
Screen for calcineurin-dependent mutants identifies three complementation groups. Further genetic analysis revealed that the five calcineurin-dependent mutations identified two different complementation groups (see Materials and Methods). Four mutants fell into a single complementation group (isolates 6, 8, 116, and 126), and the other mutant (isolate 112) identified an additional complementation group. Isolate 106, which showed slow growth in the absence of calcineurin, defined a third complementation group. We have designated the gene identified by the mutants in the first complementation group as CND1 (for calcineurin dependent) and have used the isolate number to name the cnd1 allele contained within each strain (i. e., cnd1-6, cnd1-8, cnd1-116, and cnd1-126) . We describe here a characterization of the wild-type CND1 gene and of strains containing two different cnd1 alleles.
Cloning the CND1 gene by complementation. The CND1 gene was cloned by complementing the inability of the cnd1-8 strain to grow on dextrose (see Materials and Methods for details). Three plasmids that complemented the growth defects of the cnd1-8 strain and did not encode CNA1 or CNA2 were identified. Restriction mapping analysis revealed that these plasmids contained identical inserts of 11 kb of yeast genomic DNA (Fig. 2) . These plasmids restored the ability of all cnd1 strains identified to sector and grow on dextrose and failed to restore these properties to strains in the other complementation groups.
Characterization of the CND1 gene product by DNA sequencing. The cnd1-8-complementing region was localized to a 9-kb PstI-SpeI fragment (Fig. 2) , and the complete DNA sequence of 8 kb of this fragment was determined (see Materials and Methods). This fragment contains a single long ORF that is predicted to encode a protein 1,876 amino acids in length and with a molecular weight (MW) of 215,110 (Fig. 3) . Comparison of this ORF with the database initially indicated that CND1 encodes a novel protein with no significant homology to previously characterized proteins. However, while the manu- . Hydropathy analysis of the predicted gene product encoded by CND1 revealed that, while the N terminus of the protein is quite hydrophilic, the rest of the protein contains highly hydrophobic domains that are likely to span a membrane (Fig. 4) . Thus, the protein is predicted to be an integral membrane protein that crosses an intracellular membrane at least 10 times. The 10 putative transmembrane domains are clustered in two groups, with a large intervening hydrophilic region, predicted to form an intracellular or luminal domain. Genomic location of CND1. Hybridization of a probe from the CND1-encoding plasmid to a collection of ordered lambda phage representing the yeast genome (40) revealed that the CND1 locus resides on chromosome XII, between CDC42 and ILV5. The CND1 locus is closely linked to the cnd1-8 mutation, confirming that the plasmids identified by complementation encode the same gene identified by the synthetic lethal mutations. Strain PGY6, which contains the TRP1 gene integrated upstream of the CND1 ORF (see Materials and Methods), was mated to a cnd1-8 strain (PGY2-8) and sporulated. Analysis of the resulting haploid meiotic segregants revealed that the TRP1 gene and the cnd1-8 mutation were closely linked (Յ2.4 centimorgans, 83 spores analyzed).
CND1 is not essential. We constructed a cnd1 null mutation that deleted the CND1 ORF (see Materials and Methods). The cnd1⌬1::URA3 hisG mutation was introduced into wild-type diploid yeast strains. Several heterozygous diploid transformants were sporulated, and haploid segregants from individual tetrads were analyzed. All haploid segregants from this cross, i.e., both CND1 and cnd1⌬1::URA3 hisG, were viable on YPD at 20, 30, and 37ЊC, demonstrating that CND1 is not an essential gene under these growth conditions (data not shown).
cnd1 mutants exhibit growth defects and sensitivity to FK506 and cyclosporin A. cnd1⌬1::URA3 hisG and cnd1-8 strains display two characteristic phenotypes: they are sensitive to FK506 and cyclosporin A ( 
4108
GARRETT-ENGELE ET AL. MOL. CELL. BIOL.
growing than isogenic wild-type strains (Fig. 6 ). Both of these phenotypes are more pronounced in cnd1-8 mutants than in the cnd1 deletion mutant. The sensitivities of isogenic wildtype, cnd1⌬1::URA3 hisG, and cnd1-8 strains to FK506 and cyclosporin A were compared with either dextrose or galactose as the carbon source. Under all conditions, the cnd1-8 strain was significantly more sensitive (6-to 20-fold) than the cnd1⌬1::URA3 hisG strain to either drug (see Materials and Methods). Similarly, the cnd1-8 strain exhibits a more severe growth defect than the cnd1⌬1::URA3 hisG strain (Fig. 6 ). In YPD medium at 30ЊC, the cnd1-8 strain grows with a doubling time of 450 min, compared with 270 min for the cnd1⌬1::URA3 hisG strain and 95 min for the wild-type strain (data not shown). The weaker phenotype of the cnd1⌬1 strain than of the cnd1-8 strain suggests that the cnd1-8 mutation, rather than being a simple loss-of-function allele, produces a protein that interferes to some extent with a cellular function (see Discussion). Phenotypes of cnd1 mutants vary with carbon source. The degree of drug sensitivity of both the cnd1-8 and cnd1⌬1:: URA3 hisG strains varied depending on the carbon source. Both strains were more sensitive to the effects of either FK506 or cyclosporin A when grown with dextrose than with galactose ( Fig. 5) , with the difference in sensitivity ranging from 2.5-to 16-fold (see Materials and Methods). cnd1 mutants also displayed a greater growth defect relative to wild-type cells in dextrose than in galactose (data not shown). This difference was especially striking for the cnd1-8 mutant, which, with a doubling time of 300 min on galactose, actually grew faster than on dextrose (see above). The reason for this variation in the drug sensitivity and growth rate of cnd1 mutants depending on carbon source is not clear.
Growth of cnd1-8 mutants is improved by osmotic stabilizing agents. The CND1 gene product may perform a similar function to calcineurin in the cell; therefore, we examined cnd1-8 and cnd1⌬1::URA3 hisG mutants to see if they displayed any phenotypes that were similar to calcineurin mutants. Calcineurin mutants are sensitive to several ions, including Na ϩ and OH Ϫ (45, 46) . In contrast, cnd1 mutants showed no sensitivity to Na ϩ or OH Ϫ , and their growth actually improved in media containing cations. Adding up to 100 mM KCl, NaCl, CaCl 2 , or MgCl 2 visibly improved the growth of cnd1-8 mutants (Fig. 6) . Sorbitol, a nonionic agent, also improved the growth of this strain at concentrations of up to 1 M (Fig. 6) . With the exception of CaCl 2 , which had the greatest effect on growth, all of these treatments were equivalent ( Fig.   6 and data not shown). The growth defect of the cnd1⌬1:: URA3 hisG strain, although less severe than that of the cnd1-8 mutant (see above), was also improved by osmotic stabilizing agents (data not shown). Although the addition of osmotic stabilizers to the medium improves their growth, cnd1 mutants retain their sensitivity to FK506 and cyclosporin A under these conditions and are therefore still dependent on calcineurin for growth (data not shown).
Microscopic analysis of cnd1-8 mutant cultures reveals evidence of cell lysis. Some mutants are thought to display osmotic agent-remedial growth defects because they have fragile cell walls. In the absence of osmotic support (at either 30 or 37ЊC), these mutants undergo spontaneous cell lysis (4, 30, 35-37, 49, 58, 61) . Microscopic examination revealed evidence of lysis in cnd1 cultures. By phase-contrast microscopy, we observed significant numbers of nonrefractile ghosts in cnd1-8 cultures that were absent in wild-type cultures grown in YPD. The percentage of viable cells in liquid cultures of these strains was determined by staining with methylene blue, a blue dye that is reduced to a colorless form by viable cells. In cultures of wild-type cells growing in YPD, we observed no methylene blue-positive (i.e., dead) cells. In contrast, 25% of cnd1-8 cells were positive, and this number decreased to 10% in cultures containing an osmotic stabilizer. YPD cultures of cnd1⌬1:: URA3 hisG cells contained 4% inviable cells (data not shown). Taken together, evidence of lysis and osmotic agent-remedial growth indicate that cell integrity is compromised in cnd1-8 mutants.
pkc1 and mpk1 mutants require calcineurin for growth. A Ca 2ϩ -regulated kinase, encoded by the PKC1 gene, is required to maintain yeast cell integrity (37-39, 49, 58) . pkc1 mutants exhibit a 30% reduction in total cell wall ␤-glucan (54, 58) and undergo a lethal level of spontaneous lysis, so that a pkc1⌬ mutant can grow only when an osmotic stabilizing agent is included in the medium. This lysis phenotype is similar to but more extreme than that observed for cnd1-8 mutants. Thus, we were prompted to look for interactions between PKC1-regulated pathways and calcineurin-regulated pathways. We examined the sensitivity of a pkc1⌬ strain to FK506 and cyclosporin A. We found, as previously reported, that the pkc1 mutant grew in the presence of 1 M sorbitol. However, when either FK506 or cyclosporin A was added, pkc1 mutants were no longer able to grow even in the presence of 1 M sorbitol (Fig.  7 and data not shown) . Isogenic PKC1 strains displayed no increased sensitivity to either drug (Fig. 7 and data not shown) These observations indicate that pkc1 mutants are inviable in the absence of calcineurin. To confirm this conclusion, we characterized the meitoic segregants from strain PGY13 (heterozygous for pkc1 and cnb1); only 1 pkc1 cnb1 double mutant was recovered out of a total of 47 viable progeny (Fig. 8) . The underrepresentation of the double mutant class was statistically significant (P Ͻ 0.005), and the one double mutant strain observed was most likely due to the acquisition of a spontaneous mutation that suppressed its growth defect. The mpk1/slt2 gene encodes a MAP kinase that acts downstream of PKC1 in the same signal transduction pathway (35) . mpk1/slt2 null mutants are viable at 30ЊC but at 37ЊC are dependent on osmotic stabilizers for growth because of spontaneous lysis. We found that mpk1/slt2 mutants were hypersensitive to FK506 and cyclosporin A at 30ЊC, i.e., they were inviable when calcineurin was inhibited (Fig. 7 and data not  shown) . In contrast, the growth of an isogenic MPK1 strain was unaffected by the addition of either drug (Fig. 7 and data not shown). Consistent with these observations, when a diploid strain heterozygous for cnb1 and mpk1 (PGY14) was induced to sporulate and its haploid progeny were examined, no cnb1 mpk1 double mutant spores were recovered (P Ͻ 0.005; see Fig. 8 ). Thus, yeast cells whose integrity is compromised by mutations in the PKC1 signal transduction pathway depend on calcineurin for growth.
Constitutively active calcineurin suppresses pkc1 and mpk1 growth defects. To further explore the relationship between PKC1 and calcineurin, we examined the effects of overexpressing a calcineurin subunit in pkc1 and mpk1 mutants. Multicopy plasmids encoding a wild-type CNA2 gene product (YEpCNA2) or a C-terminally truncated CNA2 (YEpCNA2⌬) were introduced into pkc1 and mpk1 strains. C-terminal truncation of the calcineurin catalytic subunit that removes the calmodulin binding site and an inhibitory domain has been shown to produce a Ca 2ϩ -independent form of the enzyme (28, 48) . We found that overexpression of this Ca 2ϩ -independent calcineurin, but not the full-length form, improved the growth of both pkc1 and mpk1 mutants, allowing pkc1 strains to grow on YPD containing 0.5 M sorbitol and mpk1 strains to grow at 37ЊC (Fig. 9) .
In contrast, activation of the PKC1-regulated MAP kinase pathway failed to alter at least two phenotypes of calcineurin mutants. Compared with wild-type strains, calcineurin mutants exhibit increased sensitivity to MnCl 2 and an inability to recover from mating pheromone arrest (12) (13) (14) . Calcineurin mutants containing a plasmid-borne copy of BCK1-20, a dominantly activated form of this kinase (pRS314[BCK1-20] [36] ) were unaltered in their responses to MnCl 2 and pheromone (data not shown).
cnd1 mutations are synthetically lethal with mutations in the PKC1 pathway. We examined the relationship between cnd1 and elements of the PKC1 pathway by trying to construct cnd1 pkc1 and cnd1 mpk1 strains. However, no such strains were recovered, indicating that these mutations were lethal in combination (Fig. 8) . Introduction of CND1 on a multicopy plasmid into either a pkc1 or an mpk1 mutant failed to suppress their growth defects (data not shown).
vma mutants require calcineurin for vegetative growth. We observed, in the course of experiments unrelated to our synthetic lethal mutation screen, that several vma mutant strains, i.e., strains lacking a functional vacuolar H ϩ -ATPase (reviewed in reference 2), were hypersensitive to FK506 and cyclosporin A (Fig. 10) . This hypersensitivity indicates that vma mutants depend on calcineurin for vegetative growth. We demonstrated this synthetic lethality directly by sporulating diploid 
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strains heterozygous for vma mutations (marked with TRP1) and cnb1 (marked with LEU2). The genotypes of viable meiotic segregants from this diploid were determined. No Leu ϩ Trp ϩ haploids, i.e., vma cnb1 double mutants, were recovered from these crosses, and the absence of this class of spores was statistically significant in each case (P Ͻ 0.005; see Fig. 8 ). Thus, this genetic analysis and the FK506/cyclosporin A hypersensitivity of vma mutants both indicate that vma mutants are inviable in the absence of calcineurin. All vma mutants display a distinctive set of phenotypes: they are sensitive to CaCl 2 , fail to grow at pH 7 or greater, and fail to grow on nonfermentable carbon sources such as glycerol (Pet Ϫ ) (2). The two mutants identified in the synthetic lethal mutation screen that did not contain mutations in CND1 (i.e., isolates 112 and 106) do not display any of these characteristic vma phenotypes (data not shown). In fact, it is unlikely that vma mutants would be identified by this procedure, because vma ade2 strains do not develop a strong red colony color.
vma2 and cnd1 mutations are not synthetically lethal. vma mutants and cnd1 mutants each depend on the presence of calcineurin for vegetative growth on standard laboratory media. Thus, the VMA and CND1 gene products each potentially perform a physiological function that is similar to, or in some way overlaps, that of calcineurin. To further explore the functional relationship between CND1 and the vacuolar H ϩ -ATPase, we created a diploid strain that was heterozygous for the cnd1⌬1::URA3 hisG mutation and the vma2::TRP1 mutation. This strain was sporulated, and the genotype of the haploid segregants of 18 individual tetrads was determined. All possible haploid segregants from this cross were viable, including Ura ϩ Trp ϩ segregants (i.e., cnd1 vma2 double mutants). However, these segregants were even more sensitive to FK506 and cyclosporin A than either the cnd1 or vma2 single mutant strains (data not shown). , and OH Ϫ ) (6, 12, 45, 46) . Calcineurin mutants are not, however, sensitive to a general increase in osmolarity or ionic content and do not display any increased sensitivity to K , or a number of other ions (12) . In addition, calcineurin mutants die during continuous exposure to mating pheromone (12) (13) (14) , as do wild-type cells under these conditions if they are deprived of Ca 2ϩ (29) . These phenotypes suggest that calcineurin participates in the regulation of intracellular ion homeostasis. One possible explanation for the apparent dispensability of calcineurin under standard laboratory conditions is the existence of other cellular regulatory pathways that execute related functions. To learn more about the physiological functions of calcineurin and how its regulatory role may intersect with other cellular components, we conducted a screen to identify mutants that require calcineurin activity for vegetative growth. Our goal was to identify elements of regulatory pathways that may overlap in function with those regulated by calcineurin.
DISCUSSION
Identification and characterization of CND1. The genetic screen described here identified mutations in three complementation groups that cause yeast cells to depend on calcineurin for normal vegetative growth. All the mutants described exhibit increased sensitivity to the calcineurin inhibitors FK506 and cyclosporin A. One of the genes identified, CND1, was characterized in detail. It is predicted to encode a novel integral membrane protein of MW 215,110, containing at least 10 potential membrane-spanning domains.
CND1 is not essential for growth; however, we report two observations indicating a role for the CND1 gene product in maintaining cell integrity. First, microscopic examination of cnd1 cultures reveals evidence of spontaneous cell lysis. Sec- ond, the degree of lysis and the slow growth of cnd1 strains are remedied by the addition of osmotic stabilizing agents to the medium. As other mutations that cause osmotic agent-remedial lysis are known to alter the morphology and composition of the cell wall (4, 30, 35-37, 49, 55, 58, 61) , our studies suggest that cnd1 mutations may also compromise cell wall function. Recently, the CND1 gene has been independently isolated and characterized by several groups and is identical to FKS1, ETG1, and CWH53 (16, 18, 53) . Mutations in this gene were identified in screens for mutants exhibiting hypersensitivity to FK506 (18, 50) , resistance to echinocandins (17) , or sensitivity to Calcofluor White (52) . Consistent with our findings, some of these studies demonstrate that fks1 mutations affect the composition of the cell wall and are lethal in combination with mutations that eliminate calcineurin function (18, 50) . Disruptions in this gene reduce the levels of ␤1,3-glucan in the cell wall (52, 53) , and point mutations in the gene can alter the properties of ␤1,3-glucan synthase activity in vitro (16, 17) . Thus, while its exact function is not clear, the FKS1/CND1/ ETG1/CWH53 gene product seems to participate in ␤1,3-glucan synthesis in vivo.
Differential effects of cnd1 alleles may reflect interactions between FKS1/CND1 and other cell components. Comparison of two cnd1 alleles indicates that cnd1-8 cells, identified by the synthetic lethal mutation screen, are more sensitive to immunosuppressants than cells containing cnd1⌬1::URA3 hisG, a deletion allele created in vitro. The cnd1-8 allele also causes more severe growth defects and compromises cell integrity to a greater extent than does cnd1⌬1. This ability of mutant Cnd1p to interfere with cell function may indicate that Cnd1p competes with another protein of similar function in the cell for common substrates, regulators, etc. Consistent with this possibility, we have preliminary evidence suggesting the presence of a functional homolog of FKS1/CND1. We observed that in the collection of ordered clones representing the yeast genome, there was a clone from chromosome VII that displayed a substantial amount of hybridization of FKS1/CND1 probes. Plasmids containing large fragments of yeast DNA (Ͼ10 kb) from this lambda clone are capable of complementing cnd1 mutant phenotypes, suggesting that this other gene can substitute for FKS1/CND1 (22) .
Interactions between calcineurin and the PKC1 signal transduction pathway. Only a few yeast mutants that exhibit osmotic agent-remedial spontaneous cell lysis have been characterized, and most of the mutations disrupt the same signal transduction pathway. This pathway is defined by PKC1, a Ca 2ϩ -dependent protein kinase related to mammalian protein kinase C. Additional kinases, the BCK1/SLK1, MKK1, MKK2, and MPK1/ SLT2 products, have been shown by genetic analyses to act downstream of PKC1. These downstream kinases are homologous to mammalian MAP kinases and MAP kinase-activating kinases. We examined genetic interactions between FKS1/ CND1, calcineurin, and the PKC1 pathway. We found that a constitutively active, Ca 2ϩ -independent form of calcineurin partially corrects the lysis defects of pkc1 and mpk1 mutants. In contrast, overexpression of intact calcineurin failed to suppress the growth defects of these mutants, indicating that the ability of calcineurin to compensate for defects in the PKC1 pathway in vivo may be limited by the duration of the Ca 2ϩ signal itself. We also found that eliminating functional calcineurin in pkc1 or mpk1 mutants exacerbates their growth defects. Taken together, these observations suggest that rather than functioning in the same regulatory pathway, calcineurin and PKC1 perform independent but related functions in determining cell integrity. Clearly, the regulatory targets of each pathway must be established before the relationship between the two can be understood. It is intriguing, however, that in mammalian T cells, calcineurin and protein kinase C have been shown to act synergistically in activating transcription of the interleukin-2 gene (21) .
We also determined that fks1/cnd1 is synthetically lethal in combination with pkc1 or mpk1/slt2. Thus, FKS1/CND1 can be added to a growing list of genes whose products participate in cell wall synthesis and are required for the viability of pkc1 mutants. These other genes include KRE6, KRE11, KRE2, and SKN7; mutations in these genes are presumably lethal in combination with pkc1 because cell wall defects are more severe in the double mutants than in either single mutant (7, 54) . is not yet clear, the genetic interactions described here suggest that the levels of several intracellular ions may be altered in calcineurin mutants.
In addition to VMA genes, we have characterized three genes, FKS1/CND1, PKC1, and MPK1, that are required for cell integrity/cell wall morphogenesis and mutations of which are lethal in combination with calcineurin mutations. The requirement for calcineurin in these cells may be quite indirect. Mutants with fragile cell walls may be more sensitive to changes in intracellular ion homeostasis, especially if those changes also alter osmotic pressure in the cell. In other words, the synthetic lethalities described here between calcineurin and cnd1, pkc1, and mpk1 mutations may simply underscore the physiological importance of coordinately regulating ion homeostasis and cell wall morphogenesis. The stimuli that elicit Ca 2ϩ signals in yeast cells are largely undefined, but these stimuli may consist of environmental changes that require yeast cells to adjust both their intracellular ionic environment (via calcineurin) and the properties of their cell wall (via PKC1).
On the other hand, it is possible that the synthetic lethalities described here are the first indication of a direct role for calcineurin in regulating cell wall structure. This function may be uncovered only in the absence of FKS1/CND1 or the PKC1 pathway because of genetic redundancy. Redundancy is the rule rather than the exception for cell wall-biosynthetic components. Chitin, for example, is synthesized by three related isozymes, each of which plays a distinct role in chitin deposition and is responsive to different regulatory inputs (8) . Similarly, some of the components that participate in ␤1,6-glucan synthesis and assembly are encoded by multiple, related genes (54, 55) . Studies such as those reported here may lead not only to a greater understanding of calcineurin's functions but also to an understanding of the environmental cues that initiate Ca Clarification of nomenclature. In the future, we will use the FKS1 designation exclusively for this gene. The mutation reported here as cnd1-8 will be referred to as fks1-8, and the mutation reported here as cnd1⌬1::URA3 hisG will be referred to as fks1⌬3::URA3 hisG.
